Kabra Drugs Ltd
company logo

Kabra Drugs Ltd

Kabra Drugs Share Price

Pharmaceuticals
Small Cap

-

0 (0%)

Invest in Kabra Drugs Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Kabra Drugs Ltd Performance

-

-

-

-


-

-

-

-

-

Kabra Drugs Ltd Fundamentals

Read More

9.21Cr

0

2.18

8.83

0

0%

4.19

Kabra Drugs Ltd Financials

Kabra Drugs Ltd Financialsright-arrow

Kabra Drugs Ltd Shareholding Pattern

Kabra Drugs Ltd Delivery and Volume

About Kabra Drugs Ltd

Kabra Drugs Ltd was incorporated as a Limited Company on August 22, 1989. The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical. The commercial production commenc

N Aravind

1989

-

NameDesignation
B V Anatha KumarWhole Time Director & CFO
Ananthkumar ShilpaIndependent Director
Churchil Durai M JebastineIndependent Director
KUNIAMUTHUR NANJAPPAN ANANDExecutive Director
Monika SanwalCompany Sec. & Compli. Officer
A AnithaIndependent Director
N AravindManaging Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Kabra Drugs Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Kabra Drugs Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Kabra Drugs Ltd's share price is ₹9.14 as of 2024-11-09.
Kabra Drugs Ltd's P/E ratio is - times as of 2024-11-09.
Kabra Drugs Ltd's most recent financial reports indicate a price-to-book ratio of 2.18, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Kabra Drugs Ltd's market capitalization is ₹9.21 Cr as on 2024-11-09.
The current financial records of Kabra Drugs Ltd show a -% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Kabra Drugs Ltd's most recent financial filings, the company has a total asset value of ₹4.55, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Kabra Drugs Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Kabra Drugs Ltd's 52-week high and low as of 2024-11-09 are ₹9.14 and ₹9.14, respectively.